A. H. Tay

NK cells and solid tumors: therapeutic potential and persisting obstacles

L. Galluzzi, A. Lundqvist, C. Jiménez-Cortegana, 2022, Molecular Cancer.

A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

J. Hartman, X. García‐Mera, J. Azuaje, 2022, Journal for ImmunoTherapy of Cancer.

Inhibition of ERO1a and IDO1 improves dendritic cell infiltration into pancreatic ductal adenocarcinoma

N. Sze, A. H. Tay, Andreas Lundqvist, 2023, Frontiers in immunology.